REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection

A Vaillant - ACS Infectious Diseases, 2018 - ACS Publications
Nucleic acid polymers (NAPs) are broad spectrum antiviral agents whose antiviral activity in
hepatitis B virus (HBV) infection is derived from their ability to block the release of the …

Towards HBV curative therapies

RF Schinazi, M Ehteshami, L Bassit… - Liver …, 2018 - Wiley Online Library
Tremendous progress has been made over the last 2 decades to discover and develop
approaches to control hepatitis B virus (HBV) infections and to prevent the development of …

[HTML][HTML] Chronic hepatitis delta: A state-of-the-art review and new therapies

C Gilman, T Heller, C Koh - World journal of gastroenterology, 2019 - ncbi.nlm.nih.gov
Chronic delta hepatitis is the most severe form of viral hepatitis affecting nearly 65 million
people worldwide. Individuals with this devastating illness are at higher risk for developing …

Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil

A Goyal, EO Romero-Severson - Plos one, 2018 - journals.plos.org
Background Hepatitis D virus (HDV), which requires the presence of hepatitis B virus (HBV),
is a deadly yet neglected disease that rapidly leads to liver cancer and disease-induced …

[PDF][PDF] MINISTERUL SĂNĂTĂŢII, MUNCII ŞI PROTECŢIEI SOCIALE AL REPUBLICII MOLDOVA UNIVERSITATEA DE STAT DE MEDICINĂ ŞI FARMACIE ''NICOLAE …

C Natalia - 2020 - cnaa.md
АННОТАЦИЯ Чобану Наталья. Патогенные особенности ишемического инсульта у
пациентов с метаболическим синдромом, диссертация на соискание ученой степени …